Suzhou, China

Guangfeng Wang

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 4.3

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Guangfeng Wang in Cancer Treatment

Introduction

Guangfeng Wang is a prominent inventor based in Suzhou, China, known for his significant contributions to the field of biomedicine. He holds a total of six patents, focusing primarily on innovative methods for cancer treatment. His work has the potential to greatly impact therapeutic strategies in oncology.

Latest Patents

One of Guangfeng Wang's latest patents is a method for treating cancer by combining an IAP inhibitor with a modulator of an immune checkpoint molecule. This method aims to treat, suppress, reduce the severity of, lower the risk of, or inhibit the metastasis of cancer in individuals. The approach involves administering a therapeutically effective amount of both an IAP inhibitor and a modulator of an immune checkpoint molecule, with the option of including a tubulin inhibitor. Additionally, he has developed a pharmaceutical composition that combines BCL-2/BCL-XL inhibitors with a chemotherapeutic agent. This composition enhances anti-tumor effects, providing a promising avenue for cancer treatment.

Career Highlights

Guangfeng Wang has worked with notable companies in the pharmaceutical industry, including Ascentage Pharma (Suzhou) Co., Ltd. and Ascentage Pharma Co., Ltd. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects aimed at improving cancer therapies.

Collaborations

Guangfeng Wang has collaborated with esteemed colleagues such as Dajun Yang and Yifan Zhai. These partnerships have contributed to the advancement of innovative cancer treatment methodologies.

Conclusion

Guangfeng Wang's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. His patents and collaborations reflect a commitment to developing effective treatment options that could transform patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…